期刊文献+

Lp-PLA2与动脉粥样硬化性脑梗死及颈动脉粥样硬化斑块的关系探讨 被引量:14

下载PDF
导出
摘要 目的探讨血清脂蛋白相关磷脂酶A2(Lp-PLA2)与动脉粥样硬化性脑梗死和颈部血管斑块Crouse积分之间的关系。方法选取急性动脉粥样硬化性脑梗死患者75例为病例组,年龄、性别与病例组相匹配的同时期无脑血管疾病表现者65例,采用双抗体夹心酶联免疫吸附法(ELISA)检测血浆Lp-PLA2水平,同时检测血脂等生化指标,并行颈动脉超声,计算颈动脉粥样硬化斑块Crouse积分。结果 ACI组LP-PLA2水平明显高于对照组,差异有统计学意义(P<0.05)。颈动脉粥样硬化斑块组不同斑块分级中Crouse积分越高,LP-PLA2水平越高。结论 LP-PLA2可作为动脉粥样硬化性脑梗死的独立危险因素之一,对预测动脉粥样硬化性脑梗死有一定的价值。通过检测LP-PLA2浓度可以间接了解颈动脉粥样硬化的程度。
作者 吴倩 胡为民
出处 《中西医结合心脑血管病杂志》 2013年第10期1216-1217,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献13

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33055
  • 2血管超声检查指南[J].中华超声影像学杂志,2009,18(10):911-920. 被引量:276
  • 3Grouse JR, Harpold GH, Kahl FR, et al. Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B mode ultrasound[J]. Stroke, 1986,17(2) :270. 被引量:1
  • 4Grant EG, Benson CB, Moneta GL, et al. Carotid artery stenosis: Gray- scale and Doppler US diagnosis. Society of Radiologists in Ultrasound Consensus Conference[J]. Radiology, 2003,229 : 340 - 346. 被引量:1
  • 5Lavi S, Herrmann J, Lavi R, et al. Role of lipoprotein - associated phospholipase A2 in atherosclerosis[JJ. Curr Atheroscler Rep, 2008,10(3):230 - 235. 被引量:1
  • 6Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis [J]. Circulation, 2002,105 : 1135 - 1143. 被引量:1
  • 7Garg PK, McClelland RL, Jenny NS, et al. Association of lipopro- tein - associated phospholipase A(2)and endothelial function in the Multi-Ethnic Study of Atherosclerosis(MESA)[J]. Vase Med, 2011,16:247 - 252. 被引量:1
  • 8Kolodgie FD, Burke AP, Skorija KS, et al. Lipoprotein - associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis[J]. Arterioscler Thromb Vase Bi- ol,2006,26:2523 -2529. 被引量:1
  • 9Mannheim D, Herrmann J, Versari D, et al. Enhanced expression of Lp - PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques[J]. Stroke, 2008,39 : 1448 - 1455. 被引量:1
  • 10吴延华,曹勇军,刘慧慧,陈冬勤,朱雪明,刘春风.急性脑梗死患者血清脂蛋白相关磷脂酶A2活性的变化[J].中华神经科杂志,2008,41(6):381-382. 被引量:16

二级参考文献17

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33055
  • 2Stafforini DM, Tjoelker LW, McCormick SP, et al. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J Biol Chem, 1999, 274:7018-7024. 被引量:1
  • 3Zalewski A, Macphee CH. Role of lipoprotein-associated phospholipase A2 in atherosclerosis : biology, epidemiology, and possible therapeutic. Arterioscler Thromb Vase Biol, 2005, 25 : 923 -931. 被引量:1
  • 4Macphee CH, Nelson J, Zalewski A. Role of lipoproteinassociated phospholipase A2. in atherosclerosis and its potential as a therapeutic target. Currt Opin Pharmacol,2006, 6 : 154-161. 被引量:1
  • 5O' Donoghue M, Morrow DA, Sabatine MS, et al. Lipoproteinassociated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 ( PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial. Circulation, 2006, 113: 1745-1752. 被引量:1
  • 6Tsimihodimos V, Karabina SA, Tambaki AP, et al. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type Ⅱ A and type Ⅱ B. Arterioscler Thromb Vasc Biol, 2002, 22: 306-311. 被引量:1
  • 7Corsetti JP, Rainwater DL, Moss AJ, et al. High lipoprotein- associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarcfion patients. Clin Chem, 2006, 52: 1331- 1338. 被引量:1
  • 8Brilakis ES, McConnell JP, Lennon RJ, et al. Association of lipoprotein-associated phospholipase .A_2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up. Eur Heart J,2005,26: 137- 144. 被引量:1
  • 9Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies : Part II. Circulation,2003,108 : 1772-1778. 被引量:1
  • 10de Korte CL, Sierevogel MJ, Mastik F, et al. Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study. Circulation, 2002, 105 : 1627-1630. 被引量:1

共引文献33357

同被引文献104

  • 1中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1854
  • 2李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15764
  • 4李华,卫金梅.血清尿酸在冠心病患者中的变化及意义[J].医学信息(西安上半月),2007,20(6):1048-1049. 被引量:3
  • 5Cao JJ, Thach C, Manolio TA, et al. C - reactive protein, carotidintima - media thickness,and incidence of ischemic stroke in theelderly: the Cardiovascular Health Study [ J]. Circulation,2003,108(2): 166 -170. 被引量:1
  • 6Lavi S,Herrmann J, Lavi R,et al. Role of lipoprotein - associatedphospholipase A2 in atherosclerosis [ J ]. Curr Atheroscler Rep,2008,10(3) : 230 -235. 被引量:1
  • 7Garg PK, McClelland RL, Jenny NS, et al. Association of lipo-protein -associated phospholipase A2 and endothelial function inthe Multi - Ethnic Study of the Atherosclerosis ( MESA) [ J ].Vase Med, 2011,16(4) : 247 -252. 被引量:1
  • 8Zhang H,Zhang JY,Tong - Wen Sun TW,et al. Amelioration ofatherosclerosis in apolipoprotein E - deficient mice by inhibition oflipoprotein - associated phospholipase A2 [ J ]. Clin Invest Med,2013,36(1): E32-41. 被引量:1
  • 9Tsimikas S, Willeit J, Knoflach M, et al. Lipoprotein - associat-ed phospholipase A2 activity,ferritin levels,metabolic syndrome,and 10 - year cardiovascular and non - cardiovascular mortality :results from the Bruneck study [J] . Eur Heart J. 2009,30(1 ):107-115. 被引量:1
  • 10Tsimikas S,Tsironis LD,Tselepis AD. New insights into the roleof lipoprotein - associated phospholipase A2 in atheroselerosisand cardiovascular disease [ J ]. Arterioscler Thromb Vase Biol,2007, 27(10) : 2094 -2099. 被引量:1

引证文献14

二级引证文献160

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部